Dianthus Therapeutics, Inc.
Dianthus Therapeutics, Inc. scores highest on Torque (72) and lowest on Earnings (18). Its PosiPenta is 46.55 out of 100, around the middle of similar companies.
On the Penta Grid this week, Dianthus Therapeutics, Inc. is Grid #352 of 837 in the Healthcare sector in United States, and Grid #2,269 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. | 46.55 | 19 | 18 | 66 | 72 | 57 |
| Edgewise Therapeutics, Inc. | 48.33 | 7 | 30 | 81 | 66 | 58 |
| Integer Holdings Corporation | 66.39 | 42 | 82 | 100 | 52 | 56 |
| ICU Medical, Inc. | 62.73 | 33 | 91 | 83 | 52 | 55 |
| Indivior Pharmaceuticals, Inc. | 68.09 | 39 | 79 | 74 | 98 | 51 |
| Option Care Health, Inc. | 62.88 | 45 | 73 | 85 | 53 | 58 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -17.00 |
| P/B ratio | 3.44 |
EEarnings
| Trailing EPS | ₹-401.59 |
| Forward EPS | ₹-436.73 |
NNitro
| Price | 6828.00 |
| 52-week high | 11165.00 |
| 52-week low | 3051.72 |
| Fall from 52-week high | 38.8% |
TTorque
| Return on equity (ROE) | -26.07% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.18 |
| Market cap | ₹38,191 Cr |
| Insider holding | 0.12% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Dianthus Therapeutics, Inc.'s PosiPenta score?
Dianthus Therapeutics, Inc.'s PosiPenta is 46.55 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Dianthus Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Dianthus Therapeutics, Inc. is Grid #352 of 837 in the Healthcare sector in United States, and Grid #2,269 of 4,000 in United States.
Which PosiPenta pillar is strongest for Dianthus Therapeutics, Inc.?
Torque (durability), with a score of 72 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Dianthus Therapeutics, Inc.?
Earnings (growth), with a score of 18 out of 100: much weaker than most similar companies.
Has Dianthus Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 2.41 points, from 44.14 to 46.55.
PositoAI is for research and education only and is not investment advice.